Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Researchers have dosed the first participant in a clinical trial of an investigational medicine designed to lower the amount ...

Protein clumps in the brain have long been associated with Alzheimer's, but other potential causes of the condition are now ...

In the quest to understand Alzheimer's disease, recent advancements in laboratory tests are shedding light on memory loss rather than solely focusing on the traditional markers like amyloid plaques.

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

Disrupted SWS (critical for waste clearance) and REM sleep (key for memory) may impair the glymphatic system, hindering the ...

When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid plaques that are a hallmark of the disease. But the results of that ...

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...

with trontinemab highlighting the technology’s ability to enhance brain penetration beyond what has been achieved with the currently marketed mAbs, Eisai/Biogen’s Leqembi and Eli Lilly’s Kisunla. The ...